Abbott Labs Company Earnings Light on Revenues

Before you go, we thought you'd like these...
Before you go close icon

health careAbbott Laboratories (NYSE: ABT) reported second-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per share (EPS) of $0.46 on revenues of $5.45 billion. In the same period last year, Abbott reported EPS of $0.43 and revenues of $5.31 billion. Second-quarter results also compare to the Thomson Reuters consensus estimates for EPS of $0.44 and $5.52 billion in revenues.

On a GAAP basis, Abbott posted EPS of $0.30, which excludes $278 million ($0.17 a share) in charges for certain expenses.

Abbott confirmed its full-year adjusted EPS guidance of $1.98 to $2.04, in line with the consensus estimate of $2.01.

On the revenue side, Abbott said that, excluding the effects of currency exchange rates, the company's revenues rose by 4.2%. Including exchange rate effects, revenues rose by just 1.7%. U.S. sales fell by 2.8%, which was better than the 3.3% slide in the first quarter, and U.S. sales in the medical devices group fell by 5.7%, substantially better than last quarter's 12.7% slide. U.S. sales also slipped in the nutrition group, down 3.1% compared to a 2.1% gain in the first quarter. Only the diagnostics segment showed a revenue increase, up 3.4%, better than the 2.9% rise posted in the first quarter.

The company's CEO said:

All things considered, including headwinds from foreign exchange and a mixed global economy, this was a good quarter.

That is called damning with faint praise. The revenue shortfall has to be a concern for Abbott, especially the continuing decline in U.S. sales.

The company also noted that second-quarter adjusted gross margin was welcome surprise at 55%. On a GAAP basis, gross margin totaled 49.7%.

Shares of Abbott are trading up 0.2% in the premarket this morning, at $35.70 in a 52-week range of $31.64 to $72.47. Thomson Reuters had a consensus analyst price target of around $40.60 before today's report.

Filed under: Healthcare (Business) Tagged: ABT
Read Full Story

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading